On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Novo Nordisk (United States)

InstitutionResearch output, impact & collaborations

Novo Nordisk (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Novo Nordisk (United States)?

ScholarIQrecord summary

Novo Nordisk (United States) is a research organisation in Seattle, US. OpenAlex records 2,455 works and 204,265 citations for it. 823 researchers list it as their most recent affiliation.

How many works does Novo Nordisk (United States) have?

ScholarIQindexed works

Novo Nordisk (United States) has 2,455 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Novo Nordisk (United States) →

How many citations does Novo Nordisk (United States) have?

ScholarIQcitation count

Novo Nordisk (United States) has 204,265 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Novo Nordisk (United States) →

How many researchers are at Novo Nordisk (United States)?

ScholarIQresearcher count

Novo Nordisk (United States) has 823 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Novo Nordisk (United States)?

ScholarIQavg h-index

Novo Nordisk (United States) has an average h-index of 44.8 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Novo Nordisk (United States)?

ScholarIQror

The ROR for Novo Nordisk (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Novo Nordisk (United States)?

ScholarIQopenalex

The OpenAlex for Novo Nordisk (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Novo Nordisk (United States)?

ScholarIQtop researchers by citations

Thomas J. Dougherty · Photodynamic Therapy Research Studies

411 works32,764 citations

Richard D. DiMarchi · Diabetes Treatment and Management

296 works20,238 citations

Alexei Kharitonenkov · Fibroblast Growth Factor Research

99 works17,834 citations

John H. Yim · Thyroid Cancer Diagnosis and Treatment

139 works3,871 citations

Elnara Fazio‐Eynullayeva · Cardiac Health and Mental Health

46 works1,355 citations

What are the most-cited papers on Novo Nordisk (United States)?

ScholarIQmost cited works

The Metabolic State of Diabetic Monkeys Is Regulated by Fibroblast Growth Factor-21

Alexei Kharitonenkov, Victor J. Wroblewski, Anja Köester, Yunfei Chen, Cathleen K. Clutinger, Xenia T. Tigno, Barbara C. Hansen, Armen B. Shanafelt, Garret J. Etgen

Endocrinology. 2006738 Citations

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Stephanie L. Harrison, Elnara Fazio‐Eynullayeva, Deirdre A. Lane, Paula Underhill, Gregory Y.H. Lip

PLoS Medicine. 2020449 CitationsOPEN ACCESS

Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters

Jack London, Elnara Fazio‐Eynullayeva, Matvey B. Palchuk, Peter Sankey, Christopher McNair

JCO Clinical Cancer Informatics. 2020332 CitationsOPEN ACCESS

The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size

Kelly L. McCoy, Noel Jabbour, Jennifer B. Ogilvie, N. Paul Ohori, Sally E. Carty, John H. Yim

Surgery. 2007242 Citations

Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Lei Wang, Diana L. Simons, Xuyang Lu, Travis Y. Tu, Shawn T. Solomon, Roger Wang, Anthony Rosario, Christian Avalos, Daniel Schmolze, John H. Yim, James Waisman, Peter P. Lee

Nature Immunology. 2019173 CitationsOPEN ACCESS

How much of the research on Novo Nordisk (United States) is open access?

ScholarIQopen access share

58%OPEN ACCESS

Gold

33%

Green

25%

Hybrid

Bronze

Closed

42%